Cargando…
The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331500/ https://www.ncbi.nlm.nih.gov/pubmed/32622891 http://dx.doi.org/10.1016/j.jaad.2020.06.1014 |
_version_ | 1783553339946958848 |
---|---|
author | Syed, Maha N. Shin, Daniel B. Wan, Marilyn T. Winthrop, Kevin L. Gelfand, Joel M. |
author_facet | Syed, Maha N. Shin, Daniel B. Wan, Marilyn T. Winthrop, Kevin L. Gelfand, Joel M. |
author_sort | Syed, Maha N. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7331500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | by the American Academy of Dermatology, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73315002020-07-06 The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic Syed, Maha N. Shin, Daniel B. Wan, Marilyn T. Winthrop, Kevin L. Gelfand, Joel M. J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2020-11 2020-07-02 /pmc/articles/PMC7331500/ /pubmed/32622891 http://dx.doi.org/10.1016/j.jaad.2020.06.1014 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Research Letter Syed, Maha N. Shin, Daniel B. Wan, Marilyn T. Winthrop, Kevin L. Gelfand, Joel M. The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
title | The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
title_full | The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
title_fullStr | The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
title_full_unstemmed | The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
title_short | The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
title_sort | risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: a meta-estimate of pivotal trials relevant to decision making during the covid-19 pandemic |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331500/ https://www.ncbi.nlm.nih.gov/pubmed/32622891 http://dx.doi.org/10.1016/j.jaad.2020.06.1014 |
work_keys_str_mv | AT syedmahan theriskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT shindanielb theriskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT wanmarilynt theriskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT winthropkevinl theriskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT gelfandjoelm theriskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT syedmahan riskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT shindanielb riskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT wanmarilynt riskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT winthropkevinl riskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT gelfandjoelm riskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic |